A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer

Background: Current PSA-based tests used to detect prostate cancer (PCa) lack sufficient specificity, leading to significant overdetection and overtreatment. Our previous studies showed that serum fucosylated PSA (Fuc-PSA) and soluble TEK receptor tyrosine kinase (Tie-2) had the ability to predict a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Theranostics
Auteurs principaux: Song, Jin, Ma, Shiyong, Sokoll, Lori J., Eguez, Rodrigo V., Höti, Naseruddin, Zhang, Hui, Mohr, Phaedre, Dua, Renu, Patil, Dattatraya, May, Kristen Douglas, Williams, Sierra, Arnold, Rebecca, Sanda, Martin G., Chan, Daniel W., Zhang, Zhen
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2021
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120218/
https://ncbi.nlm.nih.gov/pubmed/33995654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.55676
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires